In univariate Cox models, high HER3-EGFR was associated with 2.50-fold increased risk of dying from breast cancer after adjuvant chemotherapy (p = 0.003) but not when adjuvant chemotherapy was not administered (Table 1). The gene discussed is EGFR; the disease is breast carcinoma.